首页> 中文期刊> 《国际医药卫生导报》 >氮卓斯汀联合恩再适治疗慢性荨麻疹的临床观察

氮卓斯汀联合恩再适治疗慢性荨麻疹的临床观察

摘要

Objective To observe the therapeutic effectiveness of Azelastine joint Analgecine for treatment of chronic urticaria. Methods 86 cases of chronic urticaria patients were divided into two groups randomly, treatment group with 46 patients (Azelastine joint Analgecine), 40 patients in the collator group (use Azelastine only) to compare with the therapeutic effectiveness of the two groups. Results The cure effective rate was 89.1% for the treatment group, 62.5% for the collator group, the difference between the two groups are significant(P<0.05).Conclusion The therapeutic effectiveness of Azelastine joint Analgecine for treatment of chronic urticaria is definite efficacy, it's safe.%目的 观察氮卓斯汀联合恩再适治疗慢性荨麻疹的疗效.方法 将86例慢性荨麻疹患者随机分为两组,治疗组46例(氮卓斯汀联合恩再适治疗),对照组40例(单用氮卓斯汀治疗),观察两组疗效.结果 治疗组总有效率为89.1%,对照组总有效率为62.5%,两组比较有显著性差异(P<0.05).结论 氮卓斯汀联合恩再适治疗慢性荨麻疹疗效确切,安全性良好.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号